Background Novel therapeutic options with improved efficacy and safety profiles are needed
for the prophylaxis of migraine. In recent years, the inhibition of calcitonin gene-related …

Background: Erenumab is a new medicine recently approved in the United States of
America for the preventive treatment of migraine among adults. We aimed to conduct a meta …

Objective To identify and analyze postmarketing case reports of elevated blood pressure
(BP) associated with erenumab use. Methods A retrospective analysis of postmarketing …

Background Vestibular migraine (VM) is a condition associated with migraine headache,
vertigo, dizziness, and balance disturbances. Treatment options are limited. It is unknown if …

Developing antibody agonists targeting the human apelin receptor (APJ) is a promising
therapeutic approach for the treatment of chronic heart failure. Here, we report the structure …

Objective To evaluate response to anti‐calcitonin gene–related peptide (CGRP) migraine
preventives in a real‐world community cohort of persons living with migraine and to identify …

Migraine Headache In Childhood - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter …

Multiple sclerosis (MS) is among the most common chronic neurological diseases, with a
highly variable degree of disability during its long-term course. The majority of patients …

Introduction Anti-calcitonin gene-related peptide monoclonal antibodies (anti-CGRP-mAbs)
have recently been approved for the prevention of migraine, and their safety profile is not …

Background Migraine and dizziness often coexist, with vestibular migraine (VM) presenting
with vestibular symptoms and headaches. Calcitonin gene-related peptide (CGRP) may be …